Clearline Capital’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,383
| Closed | -$33K | – | 155 |
|
|
2024
Q2 | $33K | Hold |
2,383
| – | – | ﹤0.01% | 143 |
|
|
2024
Q1 | $741K | Hold |
2,383
| – | – | 0.04% | 108 |
|
|
2023
Q4 | $624K | Hold |
2,383
| – | – | 0.04% | 88 |
|
|
2023
Q3 | $466K | Hold |
2,383
| – | – | 0.04% | 113 |
|
|
2023
Q2 | $490K | Hold |
2,383
| – | – | 0.03% | 101 |
|
|
2023
Q1 | $239K | Hold |
2,383
| – | – | 0.04% | 100 |
|
|
2022
Q4 | $374K | Hold |
2,383
| – | – | 0.07% | 104 |
|
|
2022
Q3 | $597K | Hold |
2,383
| – | – | 0.07% | 112 |
|
|
2022
Q2 | $673K | Sell |
2,383
-15
| -0.6% | -$4.24K | 0.09% | 103 |
|
|
2022
Q1 | $482K | Buy |
2,398
+1,101
| +85% | +$221K | 0.06% | 104 |
|
|
2021
Q4 | $283K | Buy |
+1,297
| New | +$283K | 0.03% | 121 |
|